Jilin Aodong Pharmaceutical Group Co., Ltd.
000623.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$20.96B
Close$
$-1.63
109.5% downside
Current Fair Value
109.5% downsideOvervalued by 109.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $20.96 Billion |
|---|---|
| Enterprise Value | $21.88 Billion |
| Dividend Yield | $0.50 (2.85%) |
| Earnings per Share | $2.12 |
| Beta | 0.53 |
| Outstanding Shares | 1,172,415,307 |
Return
| Return on Equity | 9.89% |
|---|---|
| Return on Assets | 8.78% |
| Return on Invested Capital | 0.28% |
Valuation & Multiples
| P/E Ratio | 6.33 |
|---|---|
| PEG | 11.54 |
| Price to Sales | 17.1 |
| Price to Book Ratio | 0.63 |
| Enterprise Value to Revenue | 9.77 |
| Enterprise Value to EBIT | 239.01 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Jilin Aodong Pharmaceutical Group Co., Ltd.
5,461 employees
CEO: Shuqin Guo Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally focusing on the production and distribution of a broad spectrum of pharmaceutical goods. Its product line encompasses various drug forms like oral liquids, inject...